Dukes graham (29 Ergebnisse)

Softcover. Zustand: Fine. Leichte Gebrauchsspuren; Leichte Verformung / umgeknickte Seiten; Leichte Verschmutzung / Farbtonveränderung. This book is a manual for the English like Inform programming language that can be used to create interactive fiction.

Zustand: New. In English.

Paperback. Zustand: Brand New. 1st edition. 308 pages. 9.00x6.00x0.75 inches. In Stock.

Zustand: New.

Zustand: New. In English.

Hardcover. Zustand: Good. 859 p. English.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Very Good.

Paperback. Zustand: Brand New. reprint edition. 408 pages. 9.25x6.25x1.00 inches. In Stock.

23,5 x 16 cm. Zustand: Gut. 1. Auflage.. X, 308 Seiten Innen sehr sauberer, guter Zustand. Hardcover, Pappeinband, mit den üblichen Bibliotheks-Markierungen, Stempeln und Einträgen, innen wie außen, siehe Bilder. Sehr gut. MIG-18-05A|A49 Sprache: Englisch Gewicht in Gramm: 608.

Zustand: New. In English.

Zustand: New. pp. 424.

Zustand: New. In English.

Zustand: New. 2015. Reprint. Paperback. . . . . . Books ship from the US and Ireland.

Paperback. Zustand: Brand New. 148 pages. 8.50x5.51x0.34 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Most national governments have created agencies with the responsibility for deciding which medicinal drugs should be imported or manufactured and made available through their health systems. Many of these agencies were set up some twenty years ago in the wake of the thalidomide disaster. Since that time they have developed in quite different ways in response to national, cultural and economic influences. Their direct cost is very small in comparison to overall health budgets but their indirect effects, both in terms of health and the economy, can be substantial. In 1980 the World Health Organization (WHO) Regional Office for Europe set up a series of studies of drug evaluation in the European region aimed at determining the effects of the work of regulatory agencies on the availability of drugs, on the pharmaceutical industry, and on the health of individuals in the countries concerned. This book sets that work in a historical context and describes the sources of the data used by the project team and the methods used by WHO and others in assessing the work of these agencies and its repercussions for the community. Finally, it presents an analysis of current knowledge and the plans and prospects for future research. The first draft of this book was presented to a meeting of experts in the field of drug regulation at Oslo in March 1984, and the present text embodies the views and conclusions of that meeting.…

Zustand: New. pp. 424.

Kartoniert / Broschiert. Zustand: New. The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill.

Taschenbuch. Zustand: Neu. Neuware.

Zustand: New. pp. x + 308 Illus.

Zustand: New. In English.

Hardcover. Zustand: Brand New. 320 pages. 9.30x6.30x0.90 inches. In Stock.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 572 | Sprache: Englisch | Produktart: Bücher | Adverse effects of drugs are a constant source of medical problems but also of professional and legal confrontations. More than a quarter of all malpractice suits brought against physicians or other health professionals revolve around drug injury; for drug manufacturers, civil cases brought by patients are growing problem. Where conflicts do not reach the courts they are often the subject of settlements or of decisions taken by professional disciplinary councils. Uniguely, this book analysis and documents the responsibilities which all parties bear in law and ethics to render drug treatment as safe as it can be, and the liability whidh arises when injury is siffered. Special attention is devoted to the apportionment of liability, where faults may have been made by more than one party, and to the establishment of facts in a field where the evidence is likely to be heavily challenged. The pproach is global, since drugs, their makers and their users are much the same across the world; what is more systems of law and ethics have borrowed solutions from one another, while in some parts of the world - notably in consultations between the United States, Europe and Japan, medicinal policies and regulations are fast being harmonized. Contents: Six chapters in the book document the general medical and legal background to drug safewty and injury; seven set out the duties and liability of the parties concerned ranging from health professionals through governments and institutions to the patient himself. Eight chapters provide in-depth guidance on special issues including drug injury to the unborn child, vaccines, liability in alternative medicine and existing compensation schemes.…

Zustand: gut. 2009. Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow's World In englischer Sprache. pages.

ca.19 x 12,5 cm Buch im guten bis sehr guten Zustand O-PpBd. 603 Seiten.

Gebunden. Zustand: New. Pharmaceuticals play a central role in health care throughout the world. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pra.

Zustand: NEW.

Paperback. Zustand: Brand New. 428 pages. 9.21x6.46x1.18 inches. In Stock.

Buch. Zustand: Neu. Neuware - As one of the most massive and successful business sectors, the pharmaceutical industry is a potent force for good in the community, yet its behaviour is frequently questioned: could it serve society at large better than it has done in the recent past Its own internal ethics, both in business and science, may need a careful reappraisal, as may the extent to which the law - administrative, civil and criminal - succeeds in guiding (and where neccessary contraining) it. The rules of behavior that may be considered to apply to today's pharmaceutical industry have emerged over a very long period and the process goes on. Even the immensely detailed standards for quality, safety and efficacy laid down in drug law and regulation during the second half of the twentieth century have their limitations as tools for ensuring that the public interest is well served. In particular, national and regional regulatory agencies are heavily dependent on industrial data for their decision-making, their standards and competence vary, and even the existing network of agencies does not cover the entire world. What is more there are many areas of law and regulation affecting the industry, concerning for example the pricing of medicines, the conduct of clinical studies, the health protection of workers and concern for the environment. In some fields it is indeed hardly possible to maintain standards through regulation.Professor N.M. Graham Dukes, a physician and lawyer with long term experience in industrial research management, academic study and international drug policy, provides here a powerfully documented analysis into the way this industry thinks, acts, and is viewed, and examines the current trends pointing to change.…